Cargando…
Novel synthetic cyclic integrin αvβ3 binding peptide ALOS4: antitumor activity in mouse melanoma models
ALOS4, a unique synthetic cyclic peptide without resemblance to known integrin ligand sequences, was discovered through repeated biopanning with pIII phage expressing a disulfide-constrained nonapeptide library. Binding assays using a FITC-labeled analogue demonstrated selective binding to immobiliz...
Autores principales: | Yacobovich, Shiri, Tuchinsky, Lena, Kirby, Michael, Kardash, Tetiana, Agranyoni, Oryan, Nesher, Elimelech, Redko, Boris, Gellerman, Gary, Tobi, Dror, Gurova, Katerina, Koman, Igor, Fabian, Osnat Ashur, Pinhasov, Albert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325384/ https://www.ncbi.nlm.nih.gov/pubmed/27556860 http://dx.doi.org/10.18632/oncotarget.11363 |
Ejemplares similares
-
Anti-Cancer Effects of Cyclic Peptide ALOS4 in a Human Melanoma Mouse Model
por: Levi, Bar, et al.
Publicado: (2021) -
Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma
por: Redko, Boris, et al.
Publicado: (2016) -
Fast detection of deletion breakpoints using quantitative PCR
por: Abildinova, Gulshara, et al.
Publicado: (2016) -
Targeted Modulation of Interferon Response-Related Genes with IFN-Alpha/Lambda Inhibition
por: Sur, Debpali, et al.
Publicado: (2022) -
Gut microbiota determines the social behavior of mice and induces metabolic and inflammatory changes in their adipose tissue
por: Agranyoni, Oryan, et al.
Publicado: (2021)